NAD+ health ads scrutinized as NAD recommends Reus Research modify or discontinue certain claims
The NAD concluded that the corporate lacked “competent and dependable scientific proof” to assist a number of advertising and marketing statements for the NAD+-based merchandise. The decision, prompted by a problem from competitor Niagen Biosciences Inc., cited points with the...











